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Abstract
Background:  A model for integrative medicine (IM) adapted to Swedish primary care was
previously developed. The aim of this study was to explore the feasibility of a pragmatic randomised
clinical trial to investigate the effectiveness of the IM model versus conventional primary care in the
management of patients with non-specific back/neck pain. Specific objectives included the
exploration of recruitment and retention rates, patient and care characteristics, clinical differences
and effect sizes between groups, selected outcome measures and power calculations to inform the
basis of a full-scale trial.
Methods: Eighty patients with back/neck pain of at least two weeks duration were randomised to
the two types of care. Outcome measures were standardised health related quality of life (the eight
domains of SF-36) complemented by a set of exploratory "IM tailored" outcomes targeting self-
rated disability, stress and well-being (0-10 scales); days in pain (0-14); and the use of analgesics and
health care over the last two weeks (yes/no). Data on clinical management were derived from
medical records. Outcome changes from baseline to follow-up after 16 weeks were used to
explore the differences between the groups.
Results: Seventy-five percent (80/107) of screened patients in general practice were eligible and
feasible to enrol into the trial. Eighty-two percent (36/44) of the integrative and 75% (27/36) of the
conventional care group completed follow-up after 16 weeks. Most patients had back/neck pain of
at least three months duration. Conventional care typically comprised advice and prescription of
analgesics, occasionally complemented with sick leave or a written referral to physiotherapy. IM
care generally integrated seven treatment sessions from two different types of complementary
therapies with conventional care over ten weeks. The study was underpowered to detect any
statistically significant differences between the groups. One SF-36 domain showed a clinically
relevant difference between groups that was also supported by a small distribution based effect
size, i.e. vitality (-7.3 points, Cohen's d -0.34) which was in favour of IM. There was a clinical trend
between groups showing that IM contributed to less use of prescription and non-prescription
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analgesics (-11.7 and - 9.7 percent units respectively) compared to conventional care. Exploring
clinically relevant differences and the SF-36 as the basis for a main outcome measure showed that
the sample sizes needed per arm to adequately power a full-scale trial depended on the target
domain, i.e. ranging from 60 (vitality) to 339 (role emotion).
Conclusion:  This pilot study investigated the implementation of IM in the primary care
management of non-specific back and neck pain. Recruiting patients and implementing IM in routine
clinical practice was feasible. The results warrant further exploration into different perspectives
and relevant combinations of outcome measures including the use of health resources, drugs and
cost-effectiveness to help understand the relevance of IM in primary care. Future research should
prioritise larger scale studies considering variability, pain duration and small to moderate treatment
effects.
Trial registration: Clinical trials NCT00565942
Background
Research over the last few decades has reported an
increased use of complementary therapies (CTs) [1-3] and
an integration of CTs into mainstream medical settings,
health care organisations and insurance plans [4-11].
These trends may present both new challenges and new
opportunities for health care provision. In Sweden and
elsewhere, major challenges include the great variety and
quality of CT provision within health care and a lack of
national and international recommendations of how inte-
gration of CTs with conventional care may be modelled
[12]. This lack of conceptual models for delivering inte-
grative medicine (IM) may partly be a result of a scarce
evidence base in support of IM provision within public
health care services. Most research studies have investi-
gated different CTs in isolation, i.e. assessed specific effi-
cacy of individual components in models of care. It
remains largely unknown whether comprehensive IM
models differ clinically or cost effectively from conven-
tional care provision. Pragmatic trials investigating the
comparative effectiveness of different models of care
(each with several components) have been a reported pri-
ority to gain more understanding of IM in clinical practice
[13,14].
Back and neck pain are conventionally managed in pri-
mary care, impose high costs, disability and decreased
quality of life, and are two of the most common condi-
tions treated by CTs [15-18]. Previously it has been found
that IM in acute low back pain management, where a
choice of massage, chiropractic or acupuncture was added
to usual care, was as effective as usual care alone [19]. It is
currently unknown if sub-acute to chronic back pain, for
which conventional medical care is often costly and of
limited benefit, respond differently to IM.
The current study was part of a research project exploring
IM vs. conventional primary care on a health systems
level, i.e. targeting general model effectiveness in a clinical
context [20].
We have previously reported the results from the develop-
ment of a comprehensive IM model adapted to Swedish
primary care [21]. Consequently, the next phase of this
project, and the aim of this pilot study was to explore the
feasibility of conducting a randomised clinical trial to
compare the effectiveness of the developed IM model with
conventional primary care management, i.e. treatment as
usual, for patients with non-specific back/neck pain of
subacute to chronic duration. The specific objectives
included analytical exploration of recruitment and reten-
tion rates, patient and care characteristics, clinical differ-
ences and effect sizes between groups, selected outcome
measures and power calculations supported by collected
data to inform the basis of a full-scale trial. Additional
objectives were to test the feasibility of assessment, con-
sent and data collection procedures.
Methods
Study design and setting
This explorative pilot study was conducted as a pragmatic
randomised clinical trial, purposely in the setting of four
primary care units in south suburban Stockholm. The
implementation area could to some extent be character-
ised by a socio-economic status of higher unemployment
rates, lower incomes and more welfare support and sick-
ness benefits compared to the average levels in Stockholm
[22].
Patients and randomisation
Patients consulting general practitioners for back and/or
neck pain were identified and screened for study inclusion
by physicians in routine practice at participating primary
care units from September 2004 to December 2005. Inclu-
sion criteria were 18-65 years of age, low back and/or neck
pain with or without headache of at least two weeks dura-BMC Complementary and Alternative Medicine 2009, 9:33 http://www.biomedcentral.com/1472-6882/9/33
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tion, resident of Stockholm County, literate in Swedish,
willing to be randomised, and if allocated to IM attend up
to 10 CT treatments during the study period and pay five
Euros per treatment for the first six treatments after which
no additional payment for CTs would be asked, i.e. a ceil-
ing set at 30 Euros for patients to obtain all CT treatments
in the study. Exclusion criteria included specific pathology
and severe causes of back/neck pain such as malignant
disease, vertebral fractures and severe or progressive neu-
rological symptoms.
Potential participants were referred to the study's head
general practitioner and telephoned by the research co-
ordinator for a verification of eligibility, a study presenta-
tion and verbal informed consent of willingness to partic-
ipate. Patients who fulfilled the inclusion criteria and had
no exclusions were sent written study information, base-
line questionnaires and an informed consent document.
When the questionnaires and the written signed consent
had been returned an assistant not involved in patient
care randomly allocated the patient by a computer gener-
ated procedure with no blocking or stratification giving
each participant equal probability to receive either contin-
ued usual care or the IM model of care. The research coor-
dinator was informed about the allocation and then
enrolled the patient.
Interventions and providers
Conventional management
All patients first met their general practitioners to receive
conventional care treatment plans. The conventional care
complied with the clinical practice routines of the partici-
pating primary care units and the Stockholm county
council management guidelines [23]. The guidelines for
non-specific spinal pain disorders typically recommended
advice (stay active), drug prescription (analgesics), sick
leave (limited) and physiotherapy (activity based) [23].
There was no explicit study constraint to the provided
conventional care as the study aimed to pragmatically
reflect the general practitioners' standard care and treat-
ment as usual. The general practitioners (n 35) of four
neighbouring primary care units were invited to the study
based on their involvement in back and neck pain man-
agement and interest to participate.
IM management
The model for delivering IM has been extensively
described elsewhere [21]. In short, after the conventional
care treatment plans had been advised, the IM manage-
ment included consensus based team conferences to select
and integrate relevant CTs into the management over a
period of up to 12 weeks. The IM care was provided by a
multidisciplinary IM team coordinated by a gate keeping
general practitioner with clinical knowledge and experi-
ence of CTs and eight senior licensed/certified CT provid-
ers representing Swedish massage therapy, manipulative
therapy*, shiatsu, acupuncture** and qigong, i.e. CTs
with an emerging evidence base in general [24-33]. As
treatments commenced, regular consensus case confer-
ences followed, combining conventional and CT clinical
reasoning in order to verify and improve the ongoing clin-
ical management of the patient [21]. Patients did not par-
ticipate during the consensus case conferences as it was
considered more efficient for them to take part in the
health care process by way of intermittent personal inter-
action with the IM provider team [21].
*Manipulative therapy was provided by a naprapath, one of
several health care professions in Sweden utilising manipula-
tion/mobilisation techniques to normalise joint and soft tissue
dysfunction. Other common manipulative therapy providers in
Sweden include osteopaths, chiropractors and orthopaedic
manipulative physiotherapists. **A practitioner of traditional
Chinese medicine provided acupuncture.
Outcome measures
One of the research strategies prioritised by the IM team
for this pilot study was to explore the feasibility of using
an internationally standardised outcome measure in com-
bination with a set of "IM tailored" outcomes in addition
to qualitative exploration (data reported separately else-
where) to adequately investigate the comprehensive IM
intervention [21]. Here, the reliable and valid SF-36 ques-
tionnaire [34-36] was used to explore health-related qual-
ity of life domains (physical functioning, role physical,
bodily pain, general health, vitality, social functioning,
role emotional and mental health) where a score between
0 (worst) to 100 (best) was calculated for each dimension
using standardised scoring systems. The IM tailored out-
comes were eventually set to target self reported disability,
stress, well-being, days in pain and the use of analgesics
and health care. Numerical rating scales (0-10), where 0
indicated no and 10 indicated maximum levels respec-
tively, were used to assess current disability of activities in
daily living due to back/neck pain, stress and well-being.
The disability rating scale was slightly modified from the
second dimension of the reliable, valid and responsive
Bournemouth questionnaire for back/neck pain [37,38].
The main modifications were to not specify the exact daily
activities and asking for current instead of average disabil-
ity, i.e. "How much does your back/neck pain interfere
with your daily activities?" The stress and well-being scales
were considered face valid and chosen to reflect common
question areas targeted by CT providers in clinical prac-
tice. The number of days in pain during a fixed period of
time has been valued an important indicator of pain per-
sistence [39]. Based on group consensus and pre-testing of
the selected outcome measures we stipulated an appropri-
ate recall period of two weeks. The same time frame was
chosen for assessing the face valid outcomes of selfBMC Complementary and Alternative Medicine 2009, 9:33 http://www.biomedcentral.com/1472-6882/9/33
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reported use (yes/no) of analgesics and health care in
terms of prescription and non-prescription analgesics,
conventional care and complementary care (CTs out of
study). The outcome changes between baseline and fol-
low-up after 16 weeks were used to explore and compare
the results between the IM and conventional care groups.
Data collection
Data were collected by postal questionnaires sent out two
and six weeks post the intervention period, i.e. after 12
and 16 weeks respectively. The administration of ques-
tionnaires, including up to two reminders, were managed
outside of the primary care units by research staff not
involved in the clinical care of patients. Hence all provid-
ers of care were blinded to the patient questionnaires but
not to treatment allocation. The patients' general practi-
tioners documented the conventional care treatment
plans whereas the IM team documented data on IM care
in a separate medical record specifically developed for the
study.
Statistical procedures
Quality of life data (SF-36 questionnaires) were digitally
scanned by standardised procedures at Göteborgs Univer-
sitet (HRQL gruppen, Göteborg, Sweden). Other outcome
data were double entered into EpiData 3.1 (EpiData Asso-
ciation, Odense, Denmark) by research assistants not
involved in the clinical care of patients. After cleaning and
validation the raw data was imported into Intercooled
Stata™ 9.2, (StataCorp, College Station, TX, USA) and
SPSS™ 15.0 (SPSS Inc, Chicago, IL, USA) for statistical
analyses.
Numerical variables were summarised as means, standard
deviations, mean differences and proportions of change
between baseline and follow-up after 16 weeks. The
Mann-Whitney test was used for statistical analyses of dif-
ferences between the groups for ordinal data (numerical
rating scales and quality of life) and the independent two
sample t-test was used for analysing days in pain. Dichot-
omous variables were summarised as the proportions of
patients using the different types of analgesics and health
care at the different time points.
When testing cross-sectional group differences at baseline
we used univariate analysis where the different outcome
measurements were dependent variables and the group
allocation independent. When assessing the differences in
change over time between groups we used a multiple
regression model with time point, group allocation and
the interaction term (equal to 1 if the measurement was
from the IM-group and taken at follow up, and equal to 0
otherwise). We chose to not adjust for other covariates in
the analysis. For the analysis of difference in change over
time between the groups a mixed model was applied to
account for repeated values within patients. The difference
was estimated as the interaction term being 1 if the meas-
urement was from the IM-group and taken at follow-up,
and 0 otherwise.
All patients were kept in their assigned groups. Patients
lost to follow-up, i.e. observations with missing data, were
excluded from the primary analyses. To comply with a
more comprehensive intention-to-treat strategy we did a
secondary analysis where the last observed measures were
imputed for missing data. A significance level of 5% was
used and 95% confidence intervals were reported. All p-
value calculations were two-tailed.
No previous data about our specific study population
were available and the sample size for the pilot trial was
based on a hypothesis of disability scores (exploratory
outcome). The hypothesis included that 0-10 ratings of
disability would be about equal in the two groups at base-
line, around 5. It was decided to power the study to detect
a mean improvement of at least 2 points in the integrative
medicine group vs. 1 point in the conventional care
group. This difference was hypothesised to be of clinical
relevance in order for the IM model to be advisable at fol-
low-up after 16 weeks. Applying 80% power, significance
level of 5% and assuming a standard deviation of 1.5 gave
a sample size of 36 patients per treatment arm (n = 72)
(STATA software). The sample size was increased to n =
80, which was reasoned sufficient to give an initial esti-
mate of proportion for this type of explorative study.
The research project was approved by the regional ethics
committee at Karolinska Institutet (Dnr: 668-03, 650-04
and 121-32).
Results
Recruitment and retention
About 75% of patients seeking help for back/neck pain at
the primary care units were eligible and feasible to include
in the trial, i.e. in total 107 patients were assessed for eli-
gibility to be able to include 80 patients in the study (Fig-
ure 1). Demographics and baseline characteristics were
similar between the groups, most patients had back/neck
pain of at least 3 months duration, and there were no sta-
tistically significant differences between the groups (Table
1). Of the recruited patients 82% (36/44) in the IM group
and 75% (27/36) in the conventional care group com-
pleted follow-up after 16 weeks (Figure 1). There were
nine or 25% (9/36) dropouts in the conventional care
group and eight or 18% (8/44) dropouts in the IM group
after 16 weeks (Figure 1). Age and gender characteristics of
dropouts were similar between the groups, i.e. conven-
tional care group (mean age 41 ± 9.7 years, seven women)
and IM group (mean age 38 ± 9.2 years, five women) and
there were no significant differences in outcome charac-
teristics.BMC Complementary and Alternative Medicine 2009, 9:33 http://www.biomedcentral.com/1472-6882/9/33
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About 80% of physicians from the same primary care unit
as the head general practitioner referred patients to the
trial compared to about 10% of general practitioners of
the other primary care units.
Outcome measures
Clinical differences and effect sizes between groups
One SF-36 domain showed a clinically relevant difference
between groups [40,41] that was also supported by a
small distribution based effect size [42], i.e. vitality (-7.3
points, Cohen's d -0.34) which was in favour of IM (Table
2). Self-rated disability and stress returned small clinical
differences (0.7 and 1.2 points) and small effect sizes
(Cohen's d 0.23 and 0.43) between groups supporting IM
(Table 2). The clinical use of drugs and health resources
showed a trend between groups that IM contributed to
less use of prescription and non-prescription analgesics (-
11.7 and - 9.7 percent units respectively) compared con-
ventional care (Table 3).
Statistical differences, power analysis and sample size
Both the IM and conventional primary care groups
improved over time (Tables 2 and 3). The primary analy-
sis showed that there was generally large response varia-
bility and that the study was underpowered to detect
statistically significant differences between the groups for
any of the selected outcome measures (Tables 2 and 3).
The secondary analysis (intention-to-treat) where the last
observed measures were imputed for missing data did not
change the results with lack of statistically significant dif-
ferences between the groups (data not shown).
Exploring clinically relevant differences and the use of SF-
36 as the basis for a main outcome measure in a full-scale
trial, employing 80% power, a significance level of 5%, a
10 points clinical difference in change over time between
groups [40,41] and the standard deviations derived from
our pilot data, showed that the sample size needed per
arm would range between 60 (vitality) to 339 (role emo-
tional) for the trial to be adequately powered in relation
to the main target domain.
Characteristics of care
The conventional care treatment plans were characterised
by advice (85%), prescription of analgesics (50%), some-
times complemented with short-term sick leave (33%) or
a written referral to physiotherapy (26%). The advice was
given by the general practitioner and could be categorised
into general, e.g. to stay active (33%); the use of analgesics
(15%); or recommendations about physiotherapy (37%).
Table 1: Baseline characteristics of study participants by randomised groups
Conventional care (n = 36) Integrative care (n = 44)
Age, mean (SD) 41.1 (10.4) 40.3 (9.4)
Female, % 72% 73%
EU nationality, % 89% 81%
Location of worst pain, %
Low back 53% 52%
Neck 33% 36%
Low back and neck 14% 11%
Duration of pain, %
Two weeks to three months 17% 12%
Three months or longer 83% 88%
Days with pain over the last two weeks (0-14), mean (SD) 12.1 (2.8) 11.8 (3.8)
Disability due to back/neck pain (0-10)a, mean (SD) 5.4 (2.6) 5.4 (3.0)
Stress (0-10)a, mean (SD) 5.2 (2.7) 5.6 (2.7)
Wellbeing (0-10)a, mean (SD) 4.8 (1.9) 5.1 (2.3)
Used prescription analgesics during the last two weeks, % yes 54% 45%
Used non-prescription analgesics during the last two weeks, % yes 57% 63%
Used conventional care during the last two weeks, % yes 61% 65%
Used complementary care over the last two weeks, % yes 26% 20%
SF-36 Health related quality of lifeb
Physical functioning, mean (SD) 69.4 (17.3) 70.1 (24.4)
Role physical, mean (SD) 21.5 (33.4) 29.0 (35.3)
Bodily pain, mean (SD) 32.0 (14.5) 34.0 (19.1)
General health, mean (SD) 55.1 (18.6) 56.4 (24.0)
Vitality, mean (SD) 36.4 (16.6) 32.3 (23.3)
Social functioning, mean (SD) 61.5 (24.2) 56.3 (30.0)
Role emotional, mean (SD) 54.2 (39.9) 58.3 (43.2)
Mental health, mean (SD) 63.1 (19.3) 61.1 (21.2)
aThe anchors for the numerical ratings scales were 0 (nothing) to 10 (maximum) levels of disability, stress and wellbeing respectively. bSF-36 quality 
of life domains, min-max score from 0 (worst) to 100 (best). SD, standard deviation. There were no statistically significant differences between the 
randomised groups.BMC Complementary and Alternative Medicine 2009, 9:33 http://www.biomedcentral.com/1472-6882/9/33
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CONSORT flow-chart Figure 1
CONSORT flow-chart. The flow of patients through the randomised clinical trial (CONSORT flow-chart).
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Table 2: Change in SF-36, numerical rating scales and days in pain from baseline to follow-up after 16 weeks
Conventional care Integrative care Conventional vs. integrative
Outcome measure Mean (SD) N Mean (SD) N Diff. d P
Physical functioning* 11.0 (16.8) 27 9.1 (13.2) 35 1.9 0,09 0.920
Role physical* 28.7 (46.9) 27 29.2 (39.4) 36 -0.5 -0,01 0.875
Bodily pain* 19.1 (22.5) 27 21.2 (23.4) 36 -2.1 -0,12 0.813
General health* 7.5 (21.0) 26 6.1 (10.8) 36 1.4 0,06 0.502
Vitality* 12.1 (16.6) 27 19.4 (21.8) 35 -7.3 -0,34 0.237
Social functioning* 13.4 (21.9) 27 14.6 (21.0) 36 -1.2 -0,04 0.703
Role emotional* 16.1 (44.7) 27 8.3 (48.1) 36 7.7 0,18 0.872
Mental health* 5.6 (18.9) 27 7.3 (16.0) 35 -1.7 -0,09 0.326
Disability (a) -1.2 (3.5) 26 -1.9 (2.9) 36 0.7 0,23 0.458
Stress (b) 0.2 (2.8) 26 -0.9 (2.2) 36 1.2 0,43 0.090
Well-being (c) 1.5 (2.1) 26 1.5 (2.1) 36 -0.1 -0,03 0.873
Days with pain (d) -3.1 (4.7) 26 -3.8 (5.5) 35 0.7 0,19 0.595
*SF-36 health domains, min-max score from 0 (worst) to 100 (best). Numerical rating scales targeting; (a) disability in activities of daily living due to 
back/neck pain; (b) perceived stress; (c) well-being. The anchors for the numerical ratings scales were 0 (nothing) to 10 (maximum) levels of 
disability, stress and well-being respectively. (d) Days with pain over the last two weeks (0-14). SD, standard deviation. Diff, clinical difference 
between groups in outcome change over time (suggested magnitude for SF-36; 2 small, 5 clinically relevant, 10 moderate, 20 large [40,41]). d, effect 
size by Cohen's d (0.20 small, 0.50 moderate and 0.80 large [42]). Statistical analyses by Mann-Whitney (numerical rating scales and SF-36) and 
independent two sample t-tests (days with pain).
Table 3: Change in self reported use of analgesics and health care from baseline to follow-up after 16 weeks
Conventional care Integrative care Conventional vs. 
integrative care
Type of health
resource
From % (n) To % (n) Percent units From % (n) To % (n) Percent units Diff. P OR (95% CI)
Prescription
analgesics
54.3%
(19/35)
40.0%
(10/25)
-14.3 45.5%
(20/44)
19.4%
(7/36)
-26.0 -11.7 0.325
0.34 (0.0 to 3.0)
Non-prescription
analgesics
57.1%
(20/35)
42.3%
(11/26)
-14.8 63.4%
(26/41)
38.9%
(14/36)
-24.5 -9.7 0.703
0.67 (0.1 to 5.2)
Conventional
care
61.1%
(22/36)
15.4%
(4/26)
-45.7 65.1%
(28/43)
22.2%
(8/36)
-42.9 2.8 0.720
1.38 (0.2 to 8.0)
Complementary
care
25.7%
(9/35)
33.3%
(8/24)
7.6 19.5%
(8/41)
19.4%
(7/36)
-0.1 7.5 0.762
0.75 (0.1 to 4.8)
All measures were for the self reported use over the last two weeks. Diff, difference in change over time between groups. OR, Odd's ratio. CI, 
confidence interval.BMC Complementary and Alternative Medicine 2009, 9:33 http://www.biomedcentral.com/1472-6882/9/33
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The patients in the IM group additionally attended seven
CT treatment sessions administered over a time period of
ten weeks (Table 4). The division between western/body
based CTs and eastern/energy based CTs were similar
(Table 4). Among the energy based CTs acupuncture was
less used than shiatsu (Table 4). On average the patients
attended one session of individualised activity based self-
help in the form of qigong (Table 4). Typically the
patients received two different types of CTs (Table 5).
Swedish massage was the most common therapy to be
combined with several other types of CTs. Shiatsu and
qigong were the two most common CTs to be combined
together (Table 5). Manipulative therapy was the most
common CT to be integrated as a single add-on treatment
to conventional care (Table 5). There were no reports of
crucial adverse events with either type of care.
The crude costs for the CT treatments in the IM model
were approximated to 365 € (3320 SEK). These direct
costs were calculated from estimates of non-reimbursed
CT treatment costs in Sweden (figures derived from CT
associations/representatives), i.e. Swedish massage 44 €
(400 SEK), manipulative therapy 57 € (520 SEK), shiatsu
53 € (480 SEK), acupuncture 35 € (320 SEK), and qigong
48 € (440 SEK) in relation to the average number of CT
treatments provided in the IM model (Table 4).
Assessment, consent and data collection procedures
Assessment and data collection procedures were feasible
throughout the study. This included the physicians'
screening of potential study participants during routine
clinical practice, the referral to the head general practi-
tioner and the verification of eligibility and obtaining oral
and written informed consent. However, it was not possi-
ble to verify the total number of patients screened at the
participating primary care units. Similarly, logistical barri-
ers such as incompatibility between different providers'
documentation and electronic patient record systems hin-
dered mutual access to records of conventional or comple-
mentary care provided outside of the IM-team.
Documentation of IM care was also challenging, e.g. in
terms of standardisation of recording procedures, patient
record contents and mutual terminology.
Discussion
Recruitment and retention
The patient recruitment process was feasible and resulted
in a high success rate, i.e. 75% (80/107) of screened
patients with back/neck pain were enrolled in the trial.
Facilitators may have been general practitioner assurance,
e.g. enforcing that they only had to screen regular patients
and did not have to engage in the practicalities of enroll-
ing the patients. The recruitment rate may however be an
over estimation due to logistical barriers which prevented
us from making direct comparison of the reported
number of screened patients with the actual number of
patients with back/neck pain having sought care at the
participating primary care units. The head general practi-
tioner's personal experience of professional CT provision,
e.g. Swedish massage and acupuncture, may have been an
additional recruitment facilitator. This was known to sev-
eral of the collaborating physicians and may have
increased their trust in the project and willingness to refer
patients. Adding to this we found that physicians who
worked at the same primary care unit as the head general
practitioner referred the most patients to the trial. Perhaps
regular informal contact among colleagues facilitated
opportunities for queries and constructive dialogues in
familiar biomedical terms about the rational for IM in pri-
mary care. Communicating in the same "language" in
relation to biomedicine and CTs has indeed been sug-
gested to increase understanding across different health
care disciplines [43,44].
Patients lost to follow-up displayed similar characteristics
between groups and were mostly due to no reply and
attained 25% (9/36) for conventional care and 18% (8/
44) for IM care after 16 weeks. One retention barrier may
have been the use of postal questionnaires administered
outside of the primary care units to collect data. Follow-
up strategies "closer" to the patients, e.g. on-site question-
naires or interviews by dedicated staff members not
involved in the clinical care of patients or follow-up pro-
Table 4: Categories, types and numbers of complementary treatments provided in the IM model during the treatment period
Western, body based Eastern, energy based Self help, activity based
Swedish massage Manipulative therapy* Shiatsu Acupuncture** Qigong
1.5 (2.7) 1.8 (2.6) 2.8 (3.4) 0.3 (1.6) 1.0 (1.8)
1.6 (2.6) 1.5 (2.9)
7.3 (3.2)
Table figures refer to mean (standard deviation) estimates. The average length of the treatment period was 10.2 (1.4) weeks. *Manipulative therapy 
was provided by a naprapath. **A practitioner of traditional Chinese medicine provided acupuncture.BMC Complementary and Alternative Medicine 2009, 9:33 http://www.biomedcentral.com/1472-6882/9/33
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cedures via telephone, might have been more feasible.
However, a prerequisite for such strategies include the
availability of resources and adequate funding which the
current study did not have [21]. Additional facilitators for
achieving high retention rates may include recruiting
patients via media advertising or different health related
registers, businesses or insurance companies. However,
we decided against such external recruitment approaches
reasoning that patients enrolled through active media
advertising may behave differently (e.g. more motivated),
have different socioeconomic characteristics and inten-
tions for participating (e.g. more positive towards CTs)
compared to the patients seeking regular care at their pri-
mary care units in a socioeconomically underpoverished
suburban area. Hence the selected recruitment strategy
may have increased the generalisability of findings in rela-
tion to the target population and clinical setting in the
particular area, i.e. high external validity.
No patients dropped out due to crucial adverse effects
with either type of care or due to the slight extra cost of
receiving CTs in the IM model. This supports the IM and
conventional care models as safe treatment options, as
well as the feasibility of letting patients partly contribute
to the costs for CT provision. This may have important
clinical implications for implementation and sustainabil-
ity of IM in public health care settings where CTs are not
normally reimbursed. Future studies will have to investi-
gate at what levels the economical thresholds lies and how
much patients are willing to financially contribute for IM
health services in different clinical settings.
Characteristics and costs of care
Conventional care provision complied with the recom-
mended primary care guidelines [23]. To this the IM
model integrated seven CT sessions over ten weeks, typi-
cally from two different CT types. The average number of
CT treatments was about equally distributed between the
western/body based and eastern/energy based CT catego-
ries. Acupuncture was the least provided CT, mainly due
to difficulties recruiting an acupuncturist. The IM team
compensated for this by providing shiatsu, a CT largely
sharing the philosophy of acupuncture. The focus on self-
help, activity based qigong therapy was an important
component of the IM model that may have additional
social/behavioural aspects worth exploring in future trials.
Table 5: Combinations of complementary therapies provided in the IM model
Categories Types Different CTs (n) Patients % (n)
Western Swedish massage 1 6.8 (3)
Manipulative therapy* 1 22.7 (10)
Eastern Shiatsu 1 15.9 (7)
Acupuncture** 1 4.5 (2)
Western + Eastern Manipulative therapy* + Shiatsu 2 11.4 (5)
Swedish massage + Shiatsu 2 9.1 (4)
Swedish massage + Acupuncture** 2 2.3 (1)
Eastern + Self help Shiatsu + Qigong 2 13.6 (6)
Western + Self help Swedish massage + Qigong 2 6.8 (3)
Manipulative therapy* + Qigong 2 2.3 (1)
Western + Western Swedish massage + Manipulative therapy* 2 2.3 (1)
Western + Eastern + Self help Manipulative therapy* + Shiatsu + Qigong 3 2.3 (1)
Total 100.0% (44)
Western, body based therapies: Swedish massage and manipulative therapy*. Eastern, energy based therapies: Shiatsu and acupuncture**. Self help, 
activity based therapy: Qigong. *Manipulative therapy was provided by a naprapath. **A practitioner of traditional Chinese medicine provided 
acupuncture.BMC Complementary and Alternative Medicine 2009, 9:33 http://www.biomedcentral.com/1472-6882/9/33
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Manipulative therapy was provided by a naprapath, a
common provider of this type of care in Sweden. Future
IM approaches may want to consider other recognised
manipulative therapy professions including e.g. osteo-
paths, chiropractors and orthopaedic manipulative physi-
otherapists to facilitate the recruitment of manipulative
therapy providers to IM teams.
The extra direct costs for CT treatments for achieving these
clinical results was estimated to 365 € (3320 SEK) in total.
However, this limited cost approximation did not include
data on e.g. costs for conventional care, administration,
case conferences, indirect costs or cost savings from
patient, provider or organisational perspectives. Future
studies are warranted and should consider collection of
more detailed cost related data, e.g. by cost diaries and
data base measures of health care visits and sick leave, to
gain a thorough understanding about the costs and cost-
effectiveness of IM vs. conventional care. Such evidence
has immediate implications for health policy and deci-
sion-making regarding the implementation of IM in con-
ventional primary care.
Outcomes
The pilot trial analyses did not result in any statistically
significant differences between the groups' outcome
changes over time. Imputing missing data with the last
observed measures (intention-to-treat) did not change the
results, i.e. indicating that the chosen strategy was robust
for excluding cases with missing data. Exploring outcome
differences and effect sizes between the groups returned
few clinically relevant differences. The outcome measures
that displayed the largest clinical differences supporting
IM, albeit within small ranges, were the SF-36 quality of
life domain vitality and the decreased use of prescription
and non-prescription analgesics. Clearly, less use of pre-
scription analgesics if confirmed is an important clinical
finding that may reduce reported negative side effects
linked to prolonged use of such drugs [45,46]. Other
small trends in favour of IM were seen in two of the
exploratory IM tailored outcomes in terms of decreased
disability and less stress. Perhaps the IM model due to the
individualisation of back/neck pain management by inte-
gration of CTs facilitated additional and more personal-
ized ways of supporting and empowering patients
compared to possibilities within conventional care. How-
ever, the added CT treatments for the IM group might
have exposed those patients to a more intensive manage-
ment, which in turn may help to explain the trend
towards more positive results for IM identified for some
variables. This increased "attention" effect is purposively
part of the IM model and allowed for in pragmatic and
exploratory approaches towards investigating differences
between models of care. The concurrent use of CTs out of
the study allowed for in this pragmatic pilot study,
although not actively recommended to patients (we sim-
ply monitored their self-reported use), may have contam-
inated the trial and contributed to the lack of significant
differences between groups. Nonetheless, to inflict or
restrict self-initiated health care strategies or utilisation
patterns, or to quantify and distinguish between placebo
or non-specific effects of attention from more specific
effects of e.g. isolated CT technologies or procedures,
future studies would have to use more explanatory
designs. Although such rather costly and complicated
investigations would provide high internal validity, the
generalisability of findings from such trials to regular pri-
mary health care provision can sometimes be questioned
[20].
The current results with generally small clinical differ-
ences and effect sizes between groups may challenge a nar-
row use of outcomes measures in isolation to understand
the relevance of IM in primary care. The findings may fur-
ther attest to the need of identifying additional more rele-
vant evaluation strategies, as suggested by recent
outcomes research targeting IM and complex health inter-
ventions [47]. The trend of decreased use of prescription
and non-prescription analgesics for IM in this pilot trial
may support that the use of drugs and health care
resources might indeed be one such important target area.
Aspects of prevention, lifestyle changes and health pro-
motion are other potentially important areas suggested,
e.g. in recent research on shiatsu [48], incidentally one of
the CTs in our IM model. Lastly, an iterative cycle integrat-
ing and triangulating complementing quantitative and
qualitative investigative procedures might be one of the
best approaches towards exploring complex interventions
such as the implementation of IM in clinical care settings
[49].
Summary of strengths and limitations
Strong points in this study were successful screening and
recruitment procedures; feasible CT provision within con-
ventional care; comprehensive results on the characteris-
tics of IM care with expected high external validity;
acquisition of data to explore statistical and clinical differ-
ences between groups and to adequately power a future
large-scale trial. Limitations included a relatively high
drop out rate after 16 weeks; underestimated variability
and lack of power to detect statistically significant differ-
ences between the groups; no blocking in the randomisa-
tion procedure; several outcome measures of explorative
nature lacking proper scientific validity; scarce results on
the use of health care resources, costs and cost savings. We
have discussed some implications of this for future
research strategies including the need to continue investi-
gations into relevant combinations of outcomes measures
to adequately target and understand the relevance of IM
for back and neck pain management in primary care set-
tings.BMC Complementary and Alternative Medicine 2009, 9:33 http://www.biomedcentral.com/1472-6882/9/33
Page 11 of 12
(page number not for citation purposes)
Conclusion
It has been proposed that for many patients the process of
care may be as important as the outcomes of treatment
[50] which may explain in part the relatively large utilisa-
tion of CTs among consumers and patients globally [51].
Indeed, care processes themselves may influence care out-
comes, not merely in terms of satisfaction with care but
also with respect to patients' state of health and treatment
effectiveness [50]. Accordingly, the IM model emphasized
care processes along with care outcomes, and considering
some of the clinical trends reported here, aspects of IM
care might be important to consider in primary health
care reform. In conclusion this pilot study has demon-
strated the feasibility of conducting a randomised clinical
trial comparing a model for IM with conventional pri-
mary care management of patients with non-specific
back/neck pain of mostly chronic duration. Recruiting
regular primary care patients in routine clinical practice
was feasible. Exploring clinically relevant differences and
the use of SF-36 as the basis for a main outcome measure
showed that the sample sizes needed per arm would range
from 60 (vitality) to 339 (role emotion) to adequately
power a full-scale trial. The findings attest to the need to
further investigate IM as a complex health intervention
and to continue to explore relevant combinations of out-
comes to help understand the relevance of IM in primary
care, e.g. by including patient and provider perspectives,
detailed use of drugs and health care resources and health
economic evaluations. Future research should prioritise
larger scale studies considering variability, pain duration
and small to moderate treatment effects.
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